These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8815706)

  • 1. Sorivudine: a potent inhibitor of varicella zoster virus replication.
    Whitley RJ
    Adv Exp Med Biol; 1996; 394():41-4. PubMed ID: 8815706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection.
    Whitley RJ
    Neurology; 1995 Dec; 45(12 Suppl 8):S73-5. PubMed ID: 8545030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.
    Gnann JW; Crumpacker CS; Lalezari JP; Smith JA; Tyring SK; Baum KF; Borucki MJ; Joseph WP; Mertz GJ; Steigbigel RT; Cloud GA; Soong SJ; Sherrill LC; DeHertogh DA; Whitley RJ
    Antimicrob Agents Chemother; 1998 May; 42(5):1139-45. PubMed ID: 9593141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group.
    Bodsworth NJ; Boag F; Burdge D; Généreux M; Borleffs JC; Evans BA; Modai J; Colebunders R; Thomas M; DeHertogh D; Pacelli L; Thomis J
    J Infect Dis; 1997 Jul; 176(1):103-11. PubMed ID: 9207355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus.
    Shiraki K; Ochiai H; Namazue J; Okuno T; Ogino S; Hayashi K; Yamanishi K; Takahashi M
    Antiviral Res; 1992 Jun; 18(2):209-14. PubMed ID: 1329651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
    Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB
    Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir.
    Machida H; Nishitani M
    Microbiol Immunol; 1990; 34(4):407-11. PubMed ID: 2163486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.
    Purifoy DJ; Beauchamp LM; de Miranda P; Ertl P; Lacey S; Roberts G; Rahim SG; Darby G; Krenitsky TA; Powell KL
    J Med Virol; 1993; Suppl 1():139-45. PubMed ID: 8245881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of varicella-zoster virus to thymidine analogues.
    Machida H
    Biken J; 1986 Mar; 29(1):1-6. PubMed ID: 3022708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir--and beyond.
    Darby G
    J Int Med Res; 1994; 22 Suppl 1():33A-42A. PubMed ID: 8063023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine.
    Wunderli W; Miner R; Wintsch J; von Gunten S; Hirsch HH; Hirschel B
    Clin Infect Dis; 1996 May; 22(5):864-5. PubMed ID: 8722954
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of adult varicella with sorivudine: a randomized, placebo-controlled trial.
    Wallace MR; Chamberlin CJ; Sawyer MH; Arvin AM; Harkins J; LaRocco A; Colopy MW; Bowler WA; Oldfield EC
    J Infect Dis; 1996 Aug; 174(2):249-55. PubMed ID: 8699051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral potencies of BV-araU and related nucleoside analogues against varicella-zoster virus in different cell lines.
    Machida H; Ijichi K; Ohta A; Honda M; Niimura M
    Microbiol Immunol; 1990; 34(11):959-65. PubMed ID: 1965323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
    Machida H; Nishitani M; Ashida N
    Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of liquorice powder extract against varicella zoster virus isolated from Egyptian patients.
    Shebl RI; Amin MA; Emad-Eldin A; Bin Dajem SM; Mostafa AS; Ibrahim EH; Mohamed AF
    Chang Gung Med J; 2012; 35(3):231-9. PubMed ID: 22735054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.